Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Communicable Diseases
- Communicable Diseases, Emerging
- Emerging Infectious Diseases
- Infection
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
The administration of convalescent plasma is often used for treatment of emerging infectious diseases. This natural history protocol will collect plasma from subjects that were vaccinated to or recovered from an emerging infectious disease of interest, in a manner that the plasma can be given to oth...
The administration of convalescent plasma is often used for treatment of emerging infectious diseases. This natural history protocol will collect plasma from subjects that were vaccinated to or recovered from an emerging infectious disease of interest, in a manner that the plasma can be given to other subjects as a therapeutic. Any administration of plasma to subjects will be under a separate protocol.
Tracking Information
- NCT #
- NCT02338986
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Richard T Davey, M.D. National Institute of Allergy and Infectious Diseases (NIAID)